ͶƱ±êÌâ: »î¶¯ I ¡òÄú×îÐèÒªÄÄЩӢÎÄÔ­°æҩѧÀàÊé¼®£¿ (¶àÑ¡)

• 1. D¡¯Argenio, D., Advanced Methods of Pharmacokinetic and Pharmacodynamic Syste

  31 (9.3%)

• 2. Neubert, R.; Ruttinger, H.-H., Affinity Capillary Electrophoresis in Pharmace

  2 (0.6%)

• 3. Rainsford, K. D., Aspirin and Related Drugs. CRC: 2004; p 800.

  0 (0%)

• 4. Patterson, S., Bioequivalence and Statistics in Clinical Pharmacology. Chapma

  9 (2.7%)

• 5. Akiskal, H. S., Bipolar Psychopharmacotherapy: Caring for the Patient. Wiley:

  1 (0.3%)

• 6. Begley, D. J.; Bradbury, M. W.; Kreuter, J., The Blood¨CBrain Barrier and Dru

  2 (0.6%)

• 7. Reddy, I. K.; Mehvar, R., Chirality in Drug Design and Development. crc: 2004

  7 (2.1%)

• 8. Patrick Bultinck; Jan P. Tollenaere; Hans De Winter; Langenaeker, W., Computa

  5 (1.5%)

• 9. Ekins, S.; Wang, B., Computer Applications in Pharmaceutical Research and Dev

  8 (2.4%)

• 10. Gad, S. C., Drug Discovery Handbook. Wiley-Interscience: 2005; p 1496.

  8 (2.4%)

• 11. IONESCU, C.; CAIRA, M. R., Drug Metabolism. Springer: 2006; p 430.

  33 (9.9%)

• 12. Metry, J.-M.; Meyer, U. B.; Meyer, U. A., Drug Regimen Compliance. John Wile

  0 (0%)

• 13. Schreier, H., Drug Targeting Technology: Physical, Chemical and Biological M

  6 (1.8%)

• 14. Fong, D. S.; Law, S. K.; Schmidt-Erfurth, U., Drugs in Ophthalmology. Spring

  0 (0%)

• 15. Smith, H. J.; Simons, C., Enzymes and Their Inhibitors: Drug Development. CR

  8 (2.4%)

• 17. Seethala, R., Handbook of Drug Screening Dekker: 2001; p 597.

  6 (1.8%)

• 18. Kwon, Y., Handbook of Essential Pharmocokinetics, Pharmacodynamics and Drug

  13 (3.9%)

• 19. Ohannesian, L., Handbook of Pharmaceutical Analysis Dekker: 2001; p 585.

  9 (2.7%)

• 20. Niazi, S. K., Handbook of Pharmaceutical Manufacturing Formulations: Compres

  13 (3.9%)

• 21. Niazi, S. K., Handbook of Pharmaceutical Manufacturing Formulations: Liquid

  14 (4.2%)

• 22. Niazi, S. K., Handbook of Pharmaceutical Manufacturing Formulations: Over-th

  10 (3%)

• 23. Niazi, S. K., Handbook of Pharmaceutical Manufacturing Formulations: Semisol

  12 (3.6%)

• 24. Niazi, S. K., Handbook of Pharmaceutical Manufacturing Formulations: Sterile

  15 (4.5%)

• 25. Niazi, S. K., Handbook of Pharmaceutical Manufacturing Formulations: Uncompr

  18 (5.4%)

• 26. Lieberman, J. A.; Tasman, A., Handbook of Psychiatric Drugs. John Wiley & So

  0 (0%)

• 27. Amidon, G. L.; Sad¨¦e, W., Membrane Transporters as Drug Targets Kluwer Acad

  6 (1.8%)

• 28. Macheras, P.; Iliadis, A., Modeling in Biopharmaceutics, Pharmacokinetics, a

  9 (2.7%)

• 29. Banker, D. G. S.; Rhodes, D. C. T., Modern Pharmaceutics 4th ed.; Informa He

  9 (2.7%)

• 30. Rathbone, M. J.; Hadgraft, J.; Roberts, M. S., Modified-Release Drug Deliver

  9 (2.7%)

• 31. Mitra, A., Ophthalmic Drug Delivery Systems. 2nd ed.; Informa Healthcare: 20

  0 (0%)

• 32. Reddy, I. K.; Kahn, M. A., Pharmaceutical and Clinical Calculations. 2nd ed.

  2 (0.6%)

• 33. Pedersen, O., Pharmaceutical Chemical Analysis CRC: 2006; p 176.

  10 (3%)

• 34. Peter L. Bonate, P., FCP, Pharmacokinetic-Pharmacodynamic Modeling and Simul

  22 (6.6%)

• 35. Brittain, H. G., Profiles of Drug Substances, Excipients and Related Methodo

  7 (2.1%)

• 36. Brittain, H. G., Profiles of Drug Substances, Excipients and Related Methodo

  10 (3%)

• 37. Brittain, H. G., Profiles of Drug Substances, Excipients and Related Methodo

  7 (2.1%)

• 38. Bohm, H.-J.; Schneider, G.; Mannhold, R.; Kubinyi, H.; Folkers, G., Protein-

  7 (2.1%)

• 39. Plumb, D. C., Veterinary Drug Handbook Iowa State Press: 2002; p 450.

  5 (1.5%)